Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Short Interest Up 176.3% in February

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) was the recipient of a large growth in short interest in February. As of February 15th, there was short interest totalling 25,700 shares, a growth of 176.3% from the January 31st total of 9,300 shares. Currently, 1.1% of the company’s stock are sold short. Based on an average daily volume of 87,100 shares, the short-interest ratio is currently 0.3 days.

Shuttle Pharmaceuticals Stock Up 2.2 %

SHPH stock opened at $0.61 on Friday. The stock’s 50 day moving average is $0.77 and its 200-day moving average is $1.14. Shuttle Pharmaceuticals has a twelve month low of $0.57 and a twelve month high of $4.71. The firm has a market capitalization of $2.50 million, a PE ratio of -0.15 and a beta of -1.75.

Shuttle Pharmaceuticals Company Profile

Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .